A Comparative Analysis of the Sensitivity of Multidrug Resistant (MDR) and Non-MDR Cells to Different Anthracycline Derivatives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Comparative Analysis of the Sensitivity of Multidrug Resistant (MDR) and Non-MDR Cells to Different Anthracycline Derivatives

Published:1993-01 Issue:3 Volume:9 Page:255-264
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Michieli Mariagrazia,Michelutti Angela,Damiani Daniela,Pipan Corrado,Raspadori Donatella,Lauria Francesco,Baccarani Michele

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199309147379

Reference69 articles.

1. Multidrug Resistance1

2. The multidrug resistance phenotype

3. Multidrug resistance (mdr) genes in human cancer

4. Multiple-Drug Resistance in Human Cancer

5. Flow Cytometric Analysis of Doxorubicin Accumulation in Cells From Human and Rodent Cell Lines

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come;Pharmacological Reviews;2016-06-30

2. Daunorubicin for the treatment of acute myeloid leukemia;Expert Opinion on Orphan Drugs;2014-08-21

3. Acute toxicity and effectiveness of idarubicin in childhood acute lymphoblastic leukemia;European Journal of Haematology;2009-04-24

4. Case?control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients;British Journal of Haematology;2007-01

5. Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients;British Journal of Haematology;2005-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3